The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10872 malaria professionals are enjoying the free benefits of MalariaWorld today

vaccine candidate

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

April 18, 2012 - 13:47 -- Patrick Sampao
Joanne M. Lumsden, Saule Nurmukhambetova, Anjali Yadava, et al.
Vaccine, Volume 30, Issue 22, 9 May 2012, Pages 3311-3319

MalariaWorldIn this study, groups of C57BL/6J mice were immunized subcutaneously three times with VMP001 emulsified with synthetic TLR4 (GLA) or TLR7/8 (R848) agonist in stable emulsion (SE), a combination of the TLR4 and TLR7/8 agonists, or SE alone.

Medical Condition: 
Subscribe to RSS - vaccine candidate